Search
Search Results
##search.searchResults.foundPlural##
-
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE PEDIATRIC SICKLE CELL DISEASE: OUTCOME AND LONG-TERM COMPLICATIONS, SAUDI EXPERIENCE AT KING FAISAL SPECIALIST HOSPITAL, RIYADH, SAUDI ARABIA HCT in in Severe Pediatric Sickle Cell Disease
1142PDF: 912HTML: 341 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
2035PDF: 597Suppl. Files: 280HTML: 158 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1157PDF: 820HTML: 3349 -
MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS
3294PDF: 714HTML: 704Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 177Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 180Table : Distribution of the sites of bleeding and their causes: 174 -
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1580PDF: 980HTML: 349 -
COULD PLASMA GLUCOSE (PG) INCREMENT (PG %) EXPAND THE CLINICAL WEIGHT OF OGTT? PRELIMINARY FINDINGS IN 19 TDT PATIENTS (Β-TDT) WITH NORMAL GLUCOSE TOLERANCE Plasma glucose (PG) increment (PG %) and pancretic β-cell dysfunction in thalassemia
674PDF: 485HTML: 34 -
PREVALENCE OF ANEMIA, IRON DEFICIENCY, AND IRON DEFICIENCY ANEMIA AND DIAGNOSTIC PERFORMANCE OF HEMATOLOGIC AND BIOCHEMICAL MARKERS OF SIDEROPENIA IN 1- TO 5-YEAR-OLD CHILDREN IN THRACE GREECE Prevalence of ID, IDA and anemia in Greek Thrace
1951PDF: 803HTML: 271 -
TOO MANY MOULDY JOINTS – MARIJUANA AND CHRONIC PULMONARY ASPERGILLOSIS
3108PDF: 1281HTML: 13980jdoe, Dening.MarijuanaFi7.doc: 192jdoe, Dening.MarijuanaFi6.doc: 175jdoe, Dening.MarijuanaFi5.doc: 172jdoe, Dening.MarijuanaFi4.doc: 185jdoe, Dening.MarijuanaFi3.doc: 194jdoe, Dening.MarijuanaFi2.doc: 234jdoe, Dening.MarijuanaFig1.doc: 207 -
PREVALENCE OF SICKLE CELL TRAIT IN THE SOUTHERN SUBURBS OF BEIRUT, LEBANON
4078PDF: 1001HTML: 19146 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2599PDF: 930HTML: 3594 -
WHAT ARE FUNGAL INFECTIONS?
4123PDF: 2357HTML: 27575de Pauw: 233 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2004PDF: 811HTML: 205 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
3943PDF: 1291HTML: 2250 -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: THE EXPERIENCE IN CHINA
2231PDF: 828HTML: 2125New table Chinese children with APL: 158 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1240PDF: 525HTML: 23029 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3217PDF: 1227HTML: 8098 -
SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2141PDF: 914HTML: 1624 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1531PDF: 874HTML: 972figures: 175table 1: 178table2: 177table3: 178 -
-
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2129PDF: 1452HTML: 258 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2804PDF: 1214HTML: 2686Figure 1: 166 -
I INCREASED RISK OF LYMPHOMA IN MEN INFECTED WITH TUBERCULOSIS
1112PDF: 468HTML: 308 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2361PDF: 1571HTML: 607 -
Thalassemia carrier detection among pregnant women Thalassemia carrier detection among pregnant women
1827PDF: 622HTML: 239 -
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1508PDF: 775HTML: 1468Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 176 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2366PDF: 847HTML: 2447







